10x Genomics (TXG)
(Real Time Quote from BATS)
$27.57 USD
+0.09 (0.33%)
Updated May 6, 2024 02:16 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TXG 27.57 +0.09(0.33%)
Will TXG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TXG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TXG
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
TXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
3 Medical Products Stocks Set to Beat This Earnings Season
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
Other News for TXG
Cathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough Of
First Week of TXG July 19th Options Trading
Warning: TXG is at high risk of performing badly
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)